nQ Medical is a computational biomarker that has been proven in five years of clinical trials at MIT to substantially change the way disease is managed for neuromotor and neurocognitive disorders.

Using machine learning, nQ's evaluates info captured during daily use of mechanical and touchscreen devices to detect signs of disease. It can diagnose disease earlier, track disease progression, and measure impact of therapy.